U.S. Markets open in 6 hrs 10 mins

Can This Biotech Stock Rival The First FDA-Approved Cannabis Medicine?

ALLISON GATLIN
Can This Biotech Stock Rival The First FDA-Approved Cannabis Medicine?

Zogenix stock popped Thursday after the Food and Drug Administration said the biotech company can resubmit its application for a seizure treatment without running additional studies.